Comparison of medical comorbidities in Medicare patients treated by orthopaedic surgeons and neurosurgeons throughout the USA

被引:11
|
作者
Beschloss, A. [1 ]
Mueller, J. [2 ]
Caldwell, J-M E. [2 ]
Ha, A. [2 ]
Lombardi, J. M. [2 ]
Ozturk, A. [3 ]
Lehman, R. [2 ]
Saifi, C. [1 ]
机构
[1] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA
[2] Univ Penn, Philadelphia, PA 19104 USA
[3] Univ Penn, Dept Neurol Surg, Perelman Sch Med, Philadelphia, PA USA
来源
BONE & JOINT OPEN | 2020年 / 1卷 / 06期
关键词
Medicare; comorbidity; Hierachial condition categories; Neurosurgery; Orthopaedic Surgery; UNITED-STATES; PREVALENCE; MORBIDITY; TRENDS;
D O I
10.1302/2633-1462.16.BJO-2020-0032
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
Aims Medical comorbidities are a critical factor in the decision--making process for operative management and risk--stratification. The Hierarchical Condition Categories (HCC) risk adjustment model is a powerful measure of illness severity for patients treated by surgeons. The HCC is utilized by Medicare to predict medical expenditure risk and to reimburse physicians accordingly. HCC weighs comorbidities differently to calculate risk. This study determines the prevalence of medical comorbidities and the average HCC score in Medicare patients being evaluated by neurosurgeons and orthopaedic surgeon, as well as a subset of academic spine surgeons within both specialities, in the USA. Methods The Medicare Provider Utilization and Payment Database, which is based on data from the Centers for Medicare and Medicaid Services' National Claims History Standard Analytic Files, was analyzed for this study. Every surgeon who submitted a valid Medicare Part B non-institutional claim during the 2013 calendar year was included in this study. This database was queried for medical comorbidities and HCC scores of each patient who had, at minimum, a single office visit with a surgeon. This data included 21,204 orthopaedic surgeons and 4,372 neurosurgeons across 54 states/territories in the USA. Results Orthopaedic surgeons evaluated patients with a mean HCC of 1.21, while neurosurgeons evaluated patients with a mean HCC of 1.34 (p < 0.05). The rates of specific comorbidities in patients seen by orthopaedic surgeons/neurosurgeons is as follows: Ischemic heart disease (35%/39%), diabetes (31%/33%), depression (23%/31%), chronic kidney disease (19%/23%), and heart failure (17%/19%). Conclusion Nationally, comorbidity rate and HCC value for these Medicare patients are higher than national averages for the US population, with ischemic heart disease being six-times higher, diabetes two-times higher, depression three- to four-times higher, chronic kidney disease three--times higher, and heart failure nine-times higher among patients evaluated by orthopaedic surgeons and neurosurgeons.
引用
收藏
页码:257 / 260
页数:4
相关论文
共 50 条
  • [41] A MULTICENTER, OBSERVATIONAL STUDY TO EVALUATE COMORBIDITIES IN PATIENTS ABOVE 50 YEARS OF AGE - AGING POSITIVE: A COMPARISON OF MEDICAL CHARTS AND PATIENTS SELF-REPORTED DATA
    Almeida Joana, C.
    Passaro Leonor, L. P.
    Lopes Francisca, F. L.
    VALUE IN HEALTH, 2017, 20 (09) : A792 - A793
  • [42] Comparison between COPD Assessment Test (CAT) and modified Medical Research Council (mMRC) dyspnea scores for evaluation of clinical symptoms, comorbidities and medical resources utilization in COPD patients
    Cheng, Shih-Lung
    Lin, Ching-Hsiung
    Wang, Chin-Chou
    Chan, Ming-Cheng
    Hsu, Jeng-Yuan
    Hang, Liang-Wen
    Perng, Diahn-Warng
    Yu, Chong-Jen
    Wang, Hao-Chien
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2019, 118 (01) : 429 - 435
  • [43] Long-Time Follow-up of 888 Patients Diagnosed with CLL on a Single Center: Comorbidities, Time-to-Treatment and Comparison between Treated and Untreated Patients
    Keil, Felix
    Obenaus, Lisa
    Rathkolb, Victor
    Leiner, Michael
    Spork, Robert
    Koller, Elisabeth
    Forjan, Ernst
    Simanek, Ralph
    Panny, Michael
    Lechner, Daniel
    Bohm, Alexandra
    Schonmetzler, Anabel
    Kornberger, Theresia
    Noesslinger, Thomas
    BLOOD, 2019, 134
  • [44] Deep vein thrombosis in acutely-ill medical patients: A comparison of thrombi characteristics in enoxaparin-treated patients with placebo.
    Alikhan, R
    Quinlan, DJ
    Gishen, P
    Sidhu, PS
    BLOOD, 2000, 96 (11) : 653A - 653A
  • [45] Comparison of Rheumatoid Arthritis-Related Health Care Resource Use and Comorbidities Among Patients with Rheumatoid Arthritis Treated with Adalimumab Vs. Etanercept
    Xie, Jipan
    Ganguli, Arijit
    Yang, Hongbo
    Parikh, Kejal
    Wu, Eric Q.
    Cifaldi, Mary
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S211 - S211
  • [46] Comparison of Comorbidity Scores and the Impact of Comorbidities on Length of Stay and Survival in Patients with Non-Hodgkin's Lymphoma Treated with Autologous Stem Cell Transplant
    Lepic, Kylie
    Benger, Ann
    Foley, Ronan
    Fraser, Graeme
    Marcellus, Deborah
    Saunders-Roy, Michelle
    Trus, Michael
    Adams, Anita
    Kolm, Kari
    Wiemikowski, Jennifer
    Kouroukis, C. Tom
    BLOOD, 2011, 118 (21) : 917 - 917
  • [47] Anterior cruciate ligament reconstruction learning curve study-Comparison of the first 50 consecutive patients of five orthopaedic surgeons during a 5-year follow-up
    Talme, Marjo
    Harilainen, Arsi
    Lindahl, Jan
    Bister, Ville
    KNEE, 2023, 44 : 1 - 10
  • [48] BODY MASS INDEX AND OBESITY-RELATED COMORBIDITIES AMONG PATIENTS AGED&lt;65 YEARS UNDERGOING BARIATRIC SURGERY: COMPARISON BETWEEN MEDICARE AND COMMERCIALLY-INSURED
    Johnston, S. S.
    Ramisetti, S.
    Sadik, K.
    Hsiao, C.
    Wei, D.
    Scamuffa, R.
    VALUE IN HEALTH, 2018, 21 : S245 - S246
  • [49] Does training paradigm matter? A comparison of outcomes of frail patients treated by integrated vascular surgery residency and vascular surgery fellowship-trained surgeons
    Smith, Brigitte K.
    Wilson, Tyler W.
    Perler, Bruce A.
    Allen, Chelsea M.
    Presson, Angela P.
    Brooke, Benjamin S.
    AMERICAN JOURNAL OF SURGERY, 2022, 224 (03): : 881 - 887
  • [50] Comparison of the 5 Year Medical Outcome and Quality of Life of Patients with Chronic Myeloid Leukemia Treated with Imatinib or Allogeneic Transplant
    Huang, Lisi
    Du, Xin
    Weng, Jianyu
    Lai, Peilong
    Lu, Zesheng
    Wu, Ping
    Wu, Suijing
    Luo, Chengwei
    Huang, Xin
    Geng, Suxia
    BLOOD, 2015, 126 (23)